Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis

Am J Trop Med Hyg. 2008 Feb;78(2):208-9.

Abstract

Melioidosis is an infectious disease endemic to northern Australia and Southeast Asia. In response to clinical confusion regarding the appropriate dose of amoxicillin-clavulanate, we have developed guidelines for the appropriate dosing of this second-line agent. For eradication therapy for melioidosis, we recommend 20/5 mg/kg orally, three times daily.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Amoxicillin-Potassium Clavulanate Combination / administration & dosage*
  • Anti-Bacterial Agents / administration & dosage*
  • Child
  • Drug Administration Schedule
  • Female
  • Humans
  • Infusions, Intravenous
  • Melioidosis / drug therapy*
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy

Substances

  • Anti-Bacterial Agents
  • Amoxicillin-Potassium Clavulanate Combination